Unmet Needs in Hypertension Treatment

Male healthcare worker wearing a white coat and mask checks the blood pressure of an elderly woman wearing a black mask. Using the most current definition of hypertension, systolic blood pressure (SBP) of 130 mmHg or more or diastolic blood pressure (DBP) of 80 mmHg or more, close to half of adults (47.3%) in the United States (US) had hypertension in 2013 to 2016.1 The prevalence of hypertension increases with age – from 28.2% in those 20 to 44 years of age, to 60.1% in individuals 45 to 64 years old, and 77.0% in those 65 years or older.1 Also alarming is that an estimated 10.3 million US adults have apparent treatment-resistant hypertension.2 The direct and indirect cost of hypertension is estimated to be $52.4 billion for 2016 to 2017.1 Hypertension ranks 10th in health expenditures among 154 health conditions.1

Enduring Webinars

Renal Denervation in the Treatment of Resistant Hypertension

Presenters: Sandra J. Taler, MD and Raymond R. Townsend, MD
Nirupama Ramkumar, MD

Webinar Description: In this activity you will learn from experts in the field about treating resistant hypertensive patients using renal denervation. We will focus on patient selection, assessment, management, procedural considerations, and follow-up.

Supported by an education grant from Medtronic.

Resistant Hypertension Management Options

Photo of a digital blood pressure cuff and stethoscope, both resting on a piece of paperPresenters: Vivek Bhalla, MD; Robert Carey, MD, MACP; Jordana Cohen, MD, MSCE
Moderator: Lydia Bazzano, MD, PhD

Contributing to a high prevalence of hypertension is suboptimal awareness and blood pressure (BP) control. The continual increase in high blood pressure and poor rates of control indicates the need for improved assessment and management of resistant hypertension. Resistant hypertension is blood pressure that remains above goal despite concurrent use of three or more BP lowering medications of differing drug classification. Attend this webinar to learn more about resistant hypertension therapy options.

Shared Decision-Making and Hypertension Treatment

A female healthcare professional of color shares information on a sheet of paper with an older female white patient. Both women are wearing masks. Presenters: Cheryl Dennison Himmelfarb, PhD, RN, ANP, FAHA; Giv Heidari-Bateni, MD
Moderator: Eunjoo An, PhD, RN

Shared decision-making has become a method to enhance patient involvement in health care decisions, patient-provider communication, and patient-centered care. When selecting the best hypertension management plan, your patients may have different goals and preferences for treatment. Adherence may be increased if the plan aligns with the patient’s preferences. In this webinar you will learn how to engage your patients and incorporate shared decision making into your practice. Barriers to implementing strategies will also be discussed.

Supported by an education grant from Medtronic.

Health Equity and Hypertension Treatment

Medical worker checking a woman's blood pressure, both wearing masks

Presenters: Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA, John M. Flack, MD, MPH, FAHA, FASH, MACP, Karol Watson, MD, PhD
Moderator: Olethia Chisolm, MD

In this informative webinar, experts in the field will discuss healthcare disparities in hypertension treatment and management. Strategies will be presented to reach blood pressure control for all patients. With your help, patients with hypertension will see improved outcomes.

Supported by an education grant from Medtronic.


Shared Decision-Making and Adherance

While patients may have different goals and preferences for treatment, which can make selecting the best hypertension management plan difficult, adherence may be increased if the plan aligns with the patient’s preferences. What approaches in shared decision-making may improve adherence?

In this episode clinicians and a patient discuss changes in terminology when talking about patient compliance to the use of adherence and non-adherence. These changes are part of the larger shift to shared decision-making in patient care. Listen and learn how to employ shared decision-making across a range of care settings.

Podcast Transcript (docx)

Home Blood Pressure Monitoring with Clinical Support

Home blood pressure monitoring is informative but inaccessible for some outside of strengthened clinical support. Current guidelines comprehensively address how to define, measure, and treat high blood pressure, and yet hypertension management in special patient populations has not been systematically addressed. Listen and learn how clinicians can utilize shared decision-making to better engage patients in their health care and support improved health equity.

Transcript: Podcast 2 (PDF)

Spotlight Series

Complimentary CE presentations, delivered by AHA experts at hospital grand rounds nationwide, covering the newest, evidence-based measures to prevent cardiovascular disease, the #1 killer of men and women in the US.

Here’s an overview of the Spotlight Series:

Why: Educating your team on the latest science and guidelines can improve patient care and outcomes.

How: Spotlight Series offers free case-based presentations that give powerful evidence-based practices to your team.

Who: Physicians, nurses, pharmacists and other health care professionals.

When: You decide. We seek 45 days of lead time but will try to fulfill your request based on speaker availability.

Where: Anyplace you hold a hospital grand rounds type session.

What: Unmet Needs in Hypertension Treatment

The Need for Improved Assessment and Management of Hypertension

A female home healthcare worker checks a man's blood pressure.Contributing to a high prevalence of hypertension is suboptimal awareness and blood pressure control. More than one-third of US adults (38.8%) are not aware they have hypertension.1 Although awareness of hypertension has improved in the last 2 decades, data from 2015-2018 indicate that only 50.4% of adults with hypertension are receiving treatment, and only 21.6% have their blood pressure controlled.1 Awareness, treatment, and control of high blood pressure differs by race/ethnicity, with Mexican American males having the lowest prevalence of awareness, treatment, or control.1 The continual increase in high blood pressure prevalence indicates the need for improved assessment and management of hypertension.


  1. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021: CIR0000000000000950.
  2. Carey RM, Sakhuja S, Calhoun DA, et al. Prevalence of Apparent Treatment-Resistant Hypertension in the United States. Hypertension. 2019;73(2):424-431.

This program is supported by an independent medical educational grant from Medtronic.